Intelligent Bio Solutions (INBS) Preferred Shares Issued (2020)
Intelligent Bio Solutions (INBS) recorded quarterly Preferred Shares Issued of $3.3 million in Q3 2020, up 834.68% quarter-over-quarter from $352500.0 in Q2 2020.
Intelligent Bio Solutions (INBS) Preferred Shares Issued (2020) Analysis & Trends
Intelligent Bio Solutions' Preferred Shares Issued history runs 1 years deep, the most recent figure standing at $3.3 million for Q3 2020.
- In Q3 2020, Preferred Shares Issued changed N/A year-over-year to $3.3 million; the TTM figure through Jun 2021 stood at $3.3 million (changed N/A YoY), while the FY2023 annual figure was $220578.0, changed N/A from the prior year.
- Preferred Shares Issued was $3.3 million for Q3 2020 at Intelligent Bio Solutions, up from $352500.0 in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $3.3 million in Q3 2020 to a low of $352500.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Intelligent Bio Solutions | 12.72 Mn | 11.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 3.29 Mn |
| Sep 30, 2020 | 3.29 Mn |
| Jun 30, 2020 | 352,500.00 |
| Jun 30, 2020 | 352,500.00 |